PRISM MediaWire

ONCOCYTE REPORTS Full Year 2023 FINANCIAL RESULTS

Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET

12 April 2024

Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

IRVINE, CA, April 12, 2024 - PRISM MediaWire - Oncocyte Corporation (NASDAQ: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into definitive securities purchase agreements (the “Purchase Agreements”) for the purch...

12 April 2024

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

Bio-Rad expects to make equity investment in support of deal

11 April 2024

ONCOCYTE TO ANNOUNCE FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

Conference Call and Webcast on Friday, April 12, 2024, at 5:00 a.m. PT / 8:00 a.m. ET

9 April 2024

Sono-Tek Announces Preliminary Net Sales for Q4 and FY2024 and Provides Preliminary Sales Guidance for Q1 FY2025 and FY2025

12-Month Net Sales Reached ~$19.7 million, Gain of ~31% for FY2024 ended Feb 29, 2024

8 April 2024

Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024

Pittsburgh, PA, April 03, 2024 - PrismMediaWire - Lipella Pharmaceuticals Inc., (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces that its abstract has...

5 April 2024

SKYX Announces Issuance of 8 Additional New Patents in the U.S. and International including China, Europe and 2 Patents in India, for its Advanced, Smart Home and AI Platform Technologies

SKYX Enhances its Robust Patent Portfolio Which Now Totals over 90 Issued and Pending Patents with over 30 Issued Patents

4 April 2024

Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis

Pittsburgh, PA, April 03, 2024 - Lipella Pharmaceuticals Inc., (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that the U.S. Food and Drug Administra...

3 April 2024

Sono-Tek Welcomes Dr. Adeniyi Lawal to Board of Directors

Dr. Lawal has Deep Renewable Energy Expertise in Chemical Energy Conversion Processes

3 April 2024

AmpliTech Group’s Division AGTGSS, Riding The Crest Of Its Recent O-RAN CAT B 64T64R MIMO Radio Release, Teams Up With the Open6G OTIC at the Institute for the Wireless Internet of Things (WIoT) at Northeastern University To Perform O-RAN 5G Interoperability Testing

HAUPPAUGE, April 02, 2024 - PRISM MediaWire - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, other communications networks, design of complete 5G/6G systems, global distribu...

2 April 2024